Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Need cash fast? Explore various ways to get instant cash from home and improve your financial situation today.
20,693 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
ASML, Europe’s largest semiconductor equipment maker, is poised to report second-quarter results as AI-driven demand ...
Lucid shares sank as new reports claim the EV maker is weighing drastic options, including a take-private or Chapter ...
Oil climbs back above $100 as two popular ETFs diverge in their bets. This report weighs the outlook for oih: driller...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
Nvidia is teaming with Japan to build a national AI infrastructure, signaling a major shift for investors. This artic...
ASML delivered a powerhouse quarter that suggests AI infrastructure spending remains resilient. With Intel set to rep...
Virtus InfraCap’s new VPFF ETF started trading in July 2026, offering 0.80% expenses and an actively managed approach...
A new stake in VOYA Financial by Gator Capital Management is turning heads among investors. This article breaks down ...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A FormFactor director recently sold 3,000 shares in a move that drew attention from investors. This article breaks do...